Mackenzie Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Mackenzie Financial’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,584	Closed	-$67K	–	1542
2021 Q4	$67K	Buy	21,584 +7,933	+58%	+$26.7K	﹤0.01%	1387
2021 Q3	$49K	Buy	+13,651	New	+$51.5K	﹤0.01%	1407

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Mackenzie Financial's BDSI Position: Q1 2022 in Review

Mackenzie Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 21,584 shares — an estimated $67K sold.

Mackenzie Financial first reported a position in BDSI in Q3 2021 and held it in 2 quarters. The position peaked at $67K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Mackenzie Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Mackenzie Financial sold 21,584 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $67K.
Mackenzie Financial first reported a position in BioDelivery Sciences International, Inc. in Q3 2021 and held it in 2 quarters.
Mackenzie Financial's BioDelivery Sciences International, Inc. position peaked at $67K in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Mackenzie Financial's 13F filing for Q1 2022, filed 13 May 2022.